AeroVironment is in a sustained downtrend, with the stock price declining 22.5% over the past year compared to the S&P 500's 19.1% gain. The current price of $190.89 sits at 45.7% of its 52-week range ($135.20 to $417.86), indicating the stock is closer to its low than its high. This positioning near the lower end of the range suggests the market is pricing in significant headwinds, but also presents a potential value opportunity if fundamentals improve. Short-term momentum shows mixed signals: the 1-month change is -6.6%, while the 3-month change is +3.5%, suggesting a potential bottoming process. The 1-month relative strength of -5.3% versus the S&P 500 indicates underperformance, but the 3-month relative strength of -10.0% shows the stock is still lagging. The divergence between the 1-year downtrend and the recent 3-month uptick could signal a trend reversal attempt, but confirmation is needed. Key support lies at the 52-week low of $135.20, while resistance is at the 52-week high of $417.86. A breakout above resistance would signal a powerful reversal, while a breakdown below support could accelerate losses. With a beta of 1.395, the stock is 39.5% more volatile than the market, meaning it amplifies both upside and downside moves, requiring careful position sizing.

Revenue has grown dramatically, with the most recent quarter (Q3 FY2026) reporting $408 million, up 143.4% year-over-year from $167.6 million in the prior-year quarter. This acceleration is driven by a surge in defense contracts, including a $500 million Army counter-drone award. However, the company remains unprofitable, with a net loss of $156.6 million in Q3 FY2026, compared to a net loss of $1.8 million a year ago. Gross margin compressed sharply to 17.1% from 37.7% in the prior-year quarter, reflecting a shift in product mix and higher costs. The operating margin was -5.1%, indicating that revenue growth has not yet translated to bottom-line profitability. The balance sheet shows a current ratio of 4.30, indicating strong liquidity, and a low debt-to-equity ratio of 0.19, suggesting minimal leverage. However, free cash flow was negative $19.5 million in the trailing twelve months, and the company has relied on equity issuance (common stock issued $967 million in Q1 FY2026) to fund operations and acquisitions. ROE is -6.0%, reflecting the net loss position.